Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinics
- PMID: 38367966
- PMCID: PMC10875525
- DOI: 10.1136/bmjopen-2023-076194
Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinics
Abstract
Introduction: Children with chronic medical diseases are at an unacceptable risk of hospitalisation and death from influenza and SARS-CoV-2 infections. Over the past two decades, behavioural scientists have learnt how to design non-coercive 'nudge' interventions to encourage positive health behaviours. Our study aims to evaluate the impact of multicomponent nudge interventions on the uptake of COVID-19 and influenza vaccines in medically at-risk children.
Methods and analyses: Two separate randomised controlled trials (RCTs), each with 1038 children, will enrol a total of approximately 2076 children with chronic medical conditions who are attending tertiary hospitals in South Australia, Western Australia and Victoria. Participants will be randomly assigned (1:1) to the standard care or intervention group. The nudge intervention in each RCT will consist of three text message reminders with four behavioural nudges including (1) social norm messages, (2) different messengers through links to short educational videos from a paediatrician, medically at-risk child and parent and nurse, (3) a pledge to have their child or themselves vaccinated and (4) information salience through links to the current guidelines and vaccine safety information. The primary outcome is the proportion of medically at-risk children who receive at least one dose of vaccine within 3 months of randomisation. Logistic regression analysis will be performed to determine the effect of the intervention on the probability of vaccination uptake.
Ethics and dissemination: The protocol and study documents have been reviewed and approved by the Women's and Children's Health Network Human Research Ethics Committee (HREC/22/WCHN/2022/00082). The results will be published via peer-reviewed journals and presented at scientific meetings and public forums.
Trial registration number: NCT05613751.
Keywords: COVID-19; INFECTIOUS DISEASES; Primary Prevention; Public health.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: HM acknowledges support from the National Health and Medical Research Council of Australia: Practitioner Fellowship (APP1155066). CCB acknowledges support from the National Health and Medical Research Council of Australia: Investigator Grant (APP1173163). HM is an independent investigator on clinical trials of investigational vaccines manufactured by pharmaceutical companies including Pfizer, ILiAD Biotechnologies and Merck. The institution at which HM, BW and PA are employed has received funding for investigator-led research from GlaxoSmithKline, Sanofi-Pasteur and Pfizer Vaccines. All authors receive no personal payments from industry. There are no other conflicts of interest to declare.
Similar articles
-
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol.Trials. 2023 Jul 12;24(1):454. doi: 10.1186/s13063-023-07485-9. Trials. 2023. PMID: 37438776 Free PMC article.
-
Using provider-parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol.BMJ Open. 2022 Feb 10;12(2):e053838. doi: 10.1136/bmjopen-2021-053838. BMJ Open. 2022. PMID: 35144952 Free PMC article.
-
Effects of smartphone-based chatbot intervention to increase influenza and COVID-19 vaccine uptake among South Asian ethnic minorities in Hong Kong: protocol for a randomised waitlist-controlled trial.BMJ Open. 2024 Nov 24;14(11):e080725. doi: 10.1136/bmjopen-2023-080725. BMJ Open. 2024. PMID: 39581736 Free PMC article.
-
Short Message Service Reminder Nudge for Parents and Influenza Vaccination Uptake in Children and Adolescents With Special Risk Medical Conditions: The Flutext-4U Randomized Clinical Trial.JAMA Pediatr. 2023 Apr 1;177(4):337-344. doi: 10.1001/jamapediatrics.2022.6145. JAMA Pediatr. 2023. PMID: 36806893 Free PMC article. Clinical Trial.
-
Interventions to increase COVID-19 vaccine uptake: a scoping review.Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD015270. doi: 10.1002/14651858.CD015270. Cochrane Database Syst Rev. 2022. PMID: 35920693 Free PMC article.
Cited by
-
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children.Hum Vaccin Immunother. 2025 Dec;21(1):2457198. doi: 10.1080/21645515.2025.2457198. Epub 2025 Jan 23. Hum Vaccin Immunother. 2025. PMID: 39848626 Free PMC article.
References
-
- Australian Institute of Health and Welfare 2020 . Australia’s children. cat. no. CWS 69. Canberra: AIHW; 2020. Available: https://www.aihw.gov.au/reports/children-youth/australias-children/conte...
-
- Australian Government Department of Health and Aged Care . Australian technical advisory group on Immunisation (ATAGI). Australian Immunisation Handbook. Canberra, Available: immunisationhandbook.health.gov.au
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous